Michele L R Heffernan

This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Sunovion Pharmaceuticals Inc., Sepracor, Inc., Pgi Drug Discovery LLC. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele L R Heffernan. Retrieved from https://idiyas.com/inventor/michele-l-r-heffernan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 4)

% Patents Active = 73.9

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 106(Granted Patents)

Location History:

Framingham, MA (US) (2003 - 2006)
Worcester, MA (US) (2003 - 2020)
Holliston, MA (US) (2019 - 2024)

Company Filing History:

12 out of 130

Sunovion Pharmaceuticals Inc.

Pgi Drug Discovery LLC

patents

4. 1 out of 2

Sumitomo Pharma America, Inc.

patents

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

CNS Disorders

Metabotropic Glutamate Receptor

Heteroaryl Compounds

D-Amino Acid Oxidase

Analgesic Compounds

Stereoselective Synthesis

Fused Heterocycles

Fluoro-Substituted Inhibitors

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11958862 - Compounds and compositions and uses thereof (2024-04-16),

2. 11491133 - Heteroaryl-isochroman compounds and uses thereof (2022-11-08),

3. 11186564 - Dual NAV1.2/5HT2a inhibitors for treating CNS disorders (2021-11-30),

4. 10927124 - Compounds and compositions and uses thereof (2021-02-23),

5. 10780074 - Compounds and uses thereof (2020-09-22),

6. 10640510 - Metabotrophic glutamate receptor 5 modulators and methods use thereof (2020-05-05),

7. 10533000 - Metabotrophic glutamate receptor 5 modulators and methods of use thereof (2020-01-14),

8. 10196403 - Compounds and compositions and uses thereof (2019-02-05),

9. 10196399 - Metabotrophic glutamate receptor 5 modulators and methods use thereof (2019-02-05),

10. 10077243 - Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof (2018-09-18),

11. 9708331 - Metabotrophic glutamate receptor 5 modulators and methods of use thereof (2017-07-18),

12. 9260452 - Metabotrophic glutamate receptor 5 modulators and methods of use thereof (2016-02-16),

13. 8772301 - Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof (2014-07-08),

14. 7902252 - Inhibitors of D-amino acid oxidase (2011-03-08),

15. 7884124 - Fluoro-substituted inhibitors of D-amino acid oxidase (2011-02-08),

Title: The Innovative Journey of Michele L R Heffernan

Introduction: Michele L R Heffernan is a pioneering inventor based in Worcester, MA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michele L R Heffernan holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Michele L R Heffernan has worked with top research institutions and leading companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout her career, Michele L R Heffernan has collaborated with renowned scientists, engineers, and inventors, fostering a culture of innovation and excellence in all her projects.

Conclusion: Michele L R Heffernan's passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.